Friday, September 12, 2025

Latest

CloudMD Hits $39.2 Million In Revenue, $4.3 Million Net Loss In Q3 2021

CloudMD Software & Services Inc. (TSXV: DOC) released on Monday its Q3 2021 financial results which saw the company post quarterly revenue of $39.2 million, as expected from the preliminary results the firm previously announced. This is an increase from Q2 2021’s revenue of $15.7 million and Q3 2020’s revenue of $3.4 million.

“This was a milestone quarter for CloudMD as it’s the first quarter we recognized full revenue contributions from all the recently closed acquisitions and clearly demonstrated that our whole-person, patient-centric approach to healthcare is working,” explained CloudMD CEO Dr. Essam Hamza. The company completed 4 acquisitions in the preceding quarter and 14 acquisitions in the last twelve months. 

Currently, the company said it has increased its annual revenue run rate to over $185.0 million, higher than the $155.0 million it previously announced in the preliminary results.

Looking at the financials, the gross margin for the quarter was at 34.0%, down from 35.5% last quarter and 37.5% last year. This is being attributed to the current revenue mix with lower-margin businesses taking 32% of the revenue share.

However, the firm still ended the quarter with a $4.3 million net loss compared to a $6.0 million net loss last quarter and a $2.7 million net loss last year. This quarter’s loss translates to $0.02 per share.

On the other hand, the company recorded its first positive adjusted EBITDA this quarter with $0.8 million coming from a loss of $0.7 million last quarter and $1.3 million last year.

The firm also ended the quarter with $53.7 million in cash and cash equivalents coming from a beginning balance of $60.9 million. This brings current assets balance to $82.5 million while current liabilities ended at $49.9 million.

The healthtech firm relayed that with the proposed $116.0 million acquisition of MindBeacon Holdings (TSX: MBCN), it expects to have over $60.0 million in cash and cash equivalents. Following this, Cannacord lowered their 12-month price target for the company from $3.50 to $3.00.

CloudMD Software & Services Inc. last traded at $1.33 on the TSX Venture.


Information for this briefing was found via Sedar and CloudMD Software & Services. The author has no securities related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Canaccord Reiterates Rating On CloudMD After Quarterly Results

On August 25, CloudMD Software & Services (TSXV: DOC) reported their second quarter financial results....

Saturday, August 28, 2021, 03:10:00 PM

CloudMD: Canaccord Reiterates $3.00 Price Target After Q3 Results

On November 29th, CloudMD Software & Services Inc. (TSXV: DOC) announced its third quarter financial...

Wednesday, December 1, 2021, 03:36:00 PM

CloudMD Gets Price Target Cut By Canaccord Genuity

On Monday CloudMD Software & Services Inc. (TSXV: DOC) reported its fourth quarter results for...

Wednesday, May 4, 2022, 03:06:00 PM

CloudMD Posts $8.8 Million In Revenue, $5.3 Million Net Loss For Q1 2021

CloudMD Software & Services Inc. (TSXV: DOC) last night released its Q1 2021 financial results,...

Friday, May 28, 2021, 09:29:00 AM

CloudMD Closes $13 Million Financing, Announces Up-Listing

CloudMD Software & Services (CSE: DOC) this morning announced that it has closed its previously...

Tuesday, June 2, 2020, 10:17:40 AM